Less Is More: Norwegian Drug Regulation, Antibiotic Policy, and the “Need Clause”

Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries

(2016) Marc Mendelson et al.   LANCET

Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

(2016) Kevin Outterson et al.   PLOS MEDICINE

Repairing The Broken Market For Antibiotic Innovation

(2015) Kevin Outterson et al.   HEALTH AFFAIRS

History Teaches Us That Confronting Antibiotic Resistance Requires Stronger Global Collective Action

(2015) Scott H. Podolsky et al.   JOURNAL OF LAW MEDICINE & ETHICS

Producing Standards, Producing the Nordic Region: Antibiotic Susceptibility Testing, from 1950–1970

(2014) Anne Kveim Lie   SCIENCE IN CONTEXT

Pharmaceutical research and development: what do we get for all that money?

(2012) D. W. Light et al.   BMJ-British Medical Journal

Antibiotics and the Social History of the Controlled Clinical Trial, 1950-1970

(2010) S. H. Podolsky   JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES